2026 annual financial data
Virax Biolabs Group 2026 Operating margin
Virax Biolabs Group 2026 operating margin with verified reported values.
Direct answer
Operating margin was -51,515.17%.
Operating income was -6,399,730 USD and net income was -5,023,750 USD.
Operating cash flow was -4,621,892 USD.
Get free Virax Biolabs Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,423 USD
- Operating income
- -6,399,730 USD
- Net income
- -5,023,750 USD
- Operating cash flow
- -4,621,892 USD